Alpha-interferon in present-day treatment of myeloma
Demina, E.A.; Votiakova, O.M.
Gematologiia i Transfuziologiia 41(2): 32-36
1996
ISSN/ISBN: 0234-5730 PMID: 8754159 Document Number: 465131
Document emailed within 1 workday
Related Documents
Palumbo, A.P.; Garino, A.L.; Frieri, R.; Gallone, G.; Boccadoro, M.; Pileri, A. 1990: Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy Haematologica 75(6): 576-578Gisslinger, H. 1997: Interferon alpha in the therapy of multiple myeloma Leukemia 11(Suppl 5): S52-S56
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Cooper, M.R. 1991: A review of the clinical studies of alpha-interferon in the management of multiple myeloma Seminars in Oncology 18(5 Suppl 7: 18-29
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Liu, P.; Oken, M.; Van Ness, B. 1999: Interferon-alpha protects myeloma cell lines from dexamethasone-induced apoptosis Leukemia 13(3): 473-480
Pisa, P.; Stenke, L.; Bernell, P.; Hansson, M.; Hast, R. 1990: Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients Anticancer Research 10(3): 817-820
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Corbillet, V.; Celerier, P.; Lebon, P.; Litoux, P.; Dreno, B. 1995: Development of interferon antibodies during the treatment of skin diseases with low-dose recombinant interferon alpha-2a Annales de Medecine Interne 146(6): 399-403
Tomita, S.; Okamoto, S. 2007: Role of interferon for the treatment of myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 65(12): 2285-2290
Shiozawa, S.; Chihara, K.; Shiozawa, K.; Fujita, T.; Ikegami, H.; Koyama, S.; Kurimoto, M. 1986: A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients Clinical and Experimental Immunology 66(1): 77-87
Case, D.C.; Sonneborn, H.L.; Paul, S.D.; Hiebel, J.; Boyd, M.A.; Shepp, M.A.; Dorsk, B.M.; Bonnem, E. 1986: Phase Ii study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase Cancer Treatment Reports 70(11): 1251-1254
Piatkowska-Jakubas, B.; Skotnicki, A.B.; Blicharski, J. 1988: Possibility of using interferon in the treatment of multiple myeloma Przeglad Lekarski 45(10): 747-750
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Galvani, D.; Nethersell, A.; Bottomley, J. 1987: Treatment of myelodysplasia with alpha-interferon Leukemia 1(11): 786-787
Matei, I.; Tănăsescu, C.; Voiosu, R.; Murariu, E.; Dragomir, P.; Serbănescu, A. 1998: Treatment with alpha-interferon in chronic hepatitis Romanian Journal of Internal Medicine 36(3-4): 227-237
Ballarino, P.; Castello, G.; Lerza, R. 1994: Interferon-alpha in the treatment of myeloproliferative syndromes Recenti Progressi in Medicina 85(11): 546-550
Cervantes, F.; Alcorta, I.; Escoda, L.; Montserrat, E.; Rozman, C. 1993: Alpha interferon treatment of idiopathic myelofibrosis Medicina Clinica 101(13): 498-500
Kissová, J. 2019: Interferon-alpha in the treatment of myeloproliferative diseases Vnitrni Lekarstvi 65(11): 699-703
Dhib, M.; Bakhache, E.; Postec, E.; Vanrenterghem, B.; Le Roy, F.; Azar, R.; François, A.; Boldron, A.; Amaria, R.; Ozenne, G.; Hermelin, A. 1996: Nephrotic syndrome complicating treatment with interferon alpha Presse Medicale 25(23): 1066-1068